Discover 3,064 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,064
Active & Responsive
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
for
Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness,
Location: Boston MA, Montreal, Philadelphia PA, Richmond VA,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 65
Code: NCT04786262
Phase3, Recruiting
Active & Responsive
Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency
for
Exocrine Pancreatic Insufficiency
Location: Pittsburgh PA, Columbus OH, Chicago IL, Los Angeles CA
Sponsor: Ohio State University
Sex: All
Age: 18+
Code: NCT06477159
Recruiting
Active & Responsive
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
for
Generalized Myasthenia Gravis
Location: Boston MA, New Haven CT, New Hyde Park NY,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT04202341
Recruiting
Active & Responsive
GetUp&Go: A Randomized Controlled Trial of an Intervention to Enhance Physical Activity After TBI
for
Traumatic Brain Injury
Location: Elkins Park PA
Sponsor: Albert Einstein Healthcare Network
Sex: All
Age: 18+
Code: NCT06028334
Recruiting
Active & Responsive
Belimumab With Rituximab for Primary Membranous Nephropathy
for
Membranous Nephropathy, Nephrotic Syndrome
Location: New York NY, Philadelphia PA, Baltimore MD, Bethesda MD,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 70+
Code: NCT03949855
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Temple Health Chest Initiative (THCI 2.0)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Philadelphia PA
Sponsor: Temple University
Sex: All
Age: 50 - 70+
Code: NCT06933758
Recruiting
Active & Responsive
Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
for
Sickle Cell Disease
Location: The Bronx NY, Philadelphia PA, Easton PA, Baltimore MD,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 12 - 70+
Code: NCT06439082
Phase3, Recruiting
Active & Responsive
Evaluation of Filler Injection for Chin Profile Enhancement
Location: Portland ME, Boston MA, Worcester MA, Lebanon NH,
Sponsor: Chris Goss
Sex: All
Age: 6+
Code: NCT05548283
Recruiting
Active & Responsive
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
for
Platinum-resistant Ovarian Cancer,
Location: Stony Brook NY, Greenville NC, Silver Spring MD,
Sponsor: Genelux Corporation
Sex: Female
Age: 18+
Code: NCT05281471
Phase3, Recruiting
Active & Responsive
A Translational Understanding of Obesity-Related Phenotypes Using Brain Imaging and Manipulation
for
Obesity
Location: Philadelphia PA
Sponsor: Drexel University
Sex: All
Age: 18 - 35
Code: NCT06353464
Recruiting
Active & Responsive
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
for
Healthy
Location: Halifax, Boston MA, Quebec, Garden City NY, Mineola NY,
Sponsor: Pfizer
Sex: All
Age: 0 - 49
Code: NCT07160244
Phase3, Recruiting
Active & Responsive
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO